1/16
04:54 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at
Weiss Ratings from a "sell (d-)" rating to a "hold (c-)" rating.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) was upgraded by analysts at
Weiss Ratings from a "sell (d-)" rating to a "hold (c-)" rating.
1/14
07:11 pm
alny
JPM26: 2025 a “breakout year” for rare disease biotechs [Yahoo! Finance]
Low
Report
JPM26: 2025 a “breakout year” for rare disease biotechs [Yahoo! Finance]
1/13
06:42 pm
alny
Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals (ALNY) Is Down 9.0% After Ambitious 2026 Guidance And 2030 Plan Reveal [Yahoo! Finance]
1/12
03:51 pm
alny
Adimab Reports Strong Partnering Year for 2025 [Yahoo! Finance]
Low
Report
Adimab Reports Strong Partnering Year for 2025 [Yahoo! Finance]
1/12
02:47 pm
alny
Alnylam Pharmaceuticals Unveils “Alnylam 2030” as Amvuttra Drives Breakout Growth at JPMorgan Conf. [Yahoo! Finance]
Low
Report
Alnylam Pharmaceuticals Unveils “Alnylam 2030” as Amvuttra Drives Breakout Growth at JPMorgan Conf. [Yahoo! Finance]
1/12
10:37 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Bank of America Corporation from $530.00 to $529.00. They now have a "buy" rating on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Bank of America Corporation from $530.00 to $529.00. They now have a "buy" rating on the stock.
1/12
08:04 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target raised by analysts at Needham & Company LLC from $520.00 to $529.00. They now have a "buy" rating on the stock.
Medium
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target raised by analysts at Needham & Company LLC from $520.00 to $529.00. They now have a "buy" rating on the stock.
1/12
07:17 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its "outperform" rating reaffirmed by analysts at Raymond James Financial, Inc..
1/11
05:13 pm
alny
Alnylam Launches "Alnylam 2030" Strategy to Drive Next Era of Growth and Patient Impact [Yahoo! Finance]
Medium
Report
Alnylam Launches "Alnylam 2030" Strategy to Drive Next Era of Growth and Patient Impact [Yahoo! Finance]
1/11
05:00 pm
alny
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
Medium
Report
Alnylam Launches “Alnylam 2030” Strategy to Drive Next Era of Growth and Patient Impact
1/11
09:22 am
alny
Is Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 19% ROE Better Than Average? [Yahoo! Finance]
Medium
Report
Is Alnylam Pharmaceuticals, Inc.'s (NASDAQ:ALNY) 19% ROE Better Than Average? [Yahoo! Finance]
1/8
12:50 pm
alny
Fidelity Puritan Fund Q3 2025 Commentary [Seeking Alpha]
Low
Report
Fidelity Puritan Fund Q3 2025 Commentary [Seeking Alpha]
1/8
12:20 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Truist Financial Corporation from $535.00 to $530.00. They now have a "buy" rating on the stock.
Medium
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) had its price target lowered by analysts at Truist Financial Corporation from $535.00 to $530.00. They now have a "buy" rating on the stock.
1/7
07:12 pm
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly [Yahoo! Finance]
Medium
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) Seems To Use Debt Quite Sensibly [Yahoo! Finance]
1/7
10:57 am
alny
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $500.00 price target on the stock.
Low
Report
Alnylam Pharmaceuticals (NASDAQ:ALNY) is now covered by analysts at Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $500.00 price target on the stock.
1/6
07:02 am
alny
BlackRock Health Sciences Opportunities Fund Q3 2025 Commentary [Seeking Alpha]
Low
Report
BlackRock Health Sciences Opportunities Fund Q3 2025 Commentary [Seeking Alpha]
1/5
09:15 am
alny
Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Alnylam to Webcast Presentation at 44th Annual J.P. Morgan Healthcare Conference
12/20
09:41 pm
alny
PeptiDream (TSE:4587): Assessing Valuation After New IL-17 Oral Candidate and Alnylam siRNA Milestone [Yahoo! Finance]
Low
Report
PeptiDream (TSE:4587): Assessing Valuation After New IL-17 Oral Candidate and Alnylam siRNA Milestone [Yahoo! Finance]
12/20
07:51 am
alny
Here's Why Alnylam Pharmaceuticals (ALNY) Surged in Q3 [Yahoo! Finance]
Low
Report
Here's Why Alnylam Pharmaceuticals (ALNY) Surged in Q3 [Yahoo! Finance]
12/20
07:19 am
alny
What PeptiDream (TSE:4587)'s New Oral IL-17 Program and RNAi Milestone Mean For Shareholders [Yahoo! Finance]
Low
Report
What PeptiDream (TSE:4587)'s New Oral IL-17 Program and RNAi Milestone Mean For Shareholders [Yahoo! Finance]
12/19
09:39 am
alny
Breyer Capital Expands Healthcare & Life Sciences Team With Appointment of Dr. Bret Bostwick as Venture Advisor [Yahoo! Finance]
Low
Report
Breyer Capital Expands Healthcare & Life Sciences Team With Appointment of Dr. Bret Bostwick as Venture Advisor [Yahoo! Finance]
12/18
08:28 pm
alny
Alnylam's Manufacturing Expansion and Extra-Hepatic RNAi Delivery Could Be A Game Changer For Alnylam Pharmaceuticals (ALNY) [Yahoo! Finance]
Low
Report
Alnylam's Manufacturing Expansion and Extra-Hepatic RNAi Delivery Could Be A Game Changer For Alnylam Pharmaceuticals (ALNY) [Yahoo! Finance]
12/18
07:40 am
alny
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues [Yahoo! Finance]
Low
Report
PeptiDream and Alnylam Announce Achievement of Key Milestone in siRNA Conjugate Discovery Collaboration Demonstrating Peptide-Ligand Mediated Targeted siRNA Delivery to Specific Extrahepatic Tissues [Yahoo! Finance]
12/18
07:13 am
alny
Alnylam plans $250m investment in Norton manufacturing facility, US [Yahoo! Finance]
Low
Report
Alnylam plans $250m investment in Norton manufacturing facility, US [Yahoo! Finance]
12/17
09:06 am
alny
Cambridge biotech will invest $250M in Mass. production facility, add jobs [Yahoo! Finance]
Low
Report
Cambridge biotech will invest $250M in Mass. production facility, add jobs [Yahoo! Finance]